116. The pharmaceutical industry argues that because new drugs will not be developed unless heavy development costs can be recouped in later sales, the current 20 years of protection provided by patents should be extended in the case of newly developed drugs. However, in other industries new-product development continues despite high development costs, a fact that indicates that the extension is unnecessary. Which of the following, if true, most strongly supports the pharmaceutical industry's argument against the challenge made above? 這題是不是要說明 解釋為什麼製藥和其他行業的專利權不同在發展成本皆高的情況下 那(D)An existing patent for a drug does not legally prevent pharmaceutical companies from bringing to market alternative drugs, provided they are sufficiently dissimilar to the patented drug. 我看不懂這提的意思 可以解釋一下嗎 (B)Clinical trials of new drugs, which occur after the patent is granted and before the new drug can be marketed, often now take as long as 10 years to complete. B的意思是說在新藥獲得專利之後 能夠上市之前有10年的臨床實驗 請問是因為臨床實驗需要10年 所以使得他的收入晚了10 如果沒有延長專利 會有仿冒的產品投入市場 造成損失 是這樣嗎?????? 但是其他行業勒 都不怕有這樣的問題嗎 天阿 我越想越糊塗 麻煩一下囉 orz -- 女:老闆.我要叫一桶瓦斯 我:小姐.幾點了.還在叫瓦斯啊 女:我要洗澡沒瓦斯啊.當然要叫瓦斯啊 我:我要打泡還找不到女人咧 女:我有再做.可以算你便宜一點喔.你要不要.我現在可以去你那邊 我:.......................... 來吧 --

※ 發信站: 批踢踢實業坊(ptt.cc) ◆ From: 203.73.98.104 ※ 編輯: lovekyoko 來自: 203.73.98.104 (05/29 01:33) ※ 編輯: lovekyoko 來自: 203.73.98.104 (05/29 01:43)